BioMaxima (WSE:BMX) - Hisse Senedi Fiyatı, Haberler ve Analizler

BMX Stoklara Genel Bakış

BioMaxima S.A. Polonya'da in vitro diagnostik için mikrobiyolojik besiyerleri, reaktifler ve ekipmanlar üretmekte ve dağıtmaktadır.

Şirket hakkında

BMX temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	0/6
Finansal Sağlık	5/6
Temettüler	0/6

Ödüller

Risk Analizi

Does not have a meaningful market cap (PLN62M)

Volatile share price over the past 3 months compared to the Polish market

BioMaxima S.A. Rakipler

PZ Cormay

WSE:CRM

zł41.8m

Mercator Medical

WSE:MRC

zł515.9m

MedApp

WSE:MDA

zł47.7m

Medicalgorithmics

WSE:MDG

zł227.9m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti BioMaxima
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	zł14.85
52 Haftanın En Yüksek Seviyesi	zł20.50
52 Haftanın En Düşük Seviyesi	zł12.16
Beta	-2.46
11 Aylık Değişim	3.85%
3 Aylık Değişim	-8.33%
1 Yıllık Değişim	-10.86%
33 Yıllık Değişim	-41.99%
5 Yıllık Değişim	305.74%
Halka arzdan bu yana değişim	87.97%

Son Haberler & Güncellemeler

BioMaxima (WSE:BMX) Is Carrying A Fair Bit Of Debt

Aug 22

BioMaxima S.A.'s (WSE:BMX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Jun 08

Recent updates

BioMaxima (WSE:BMX) Is Carrying A Fair Bit Of Debt

Aug 22

BioMaxima S.A.'s (WSE:BMX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Jun 08

BioMaxima S.A.'s (WSE:BMX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Apr 21

Are BioMaxima's (WSE:BMX) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jan 14

Hissedar Getirileri

	BMX	PL Medical Equipment	PL Pazar
7D	1.7%	-4.1%	-1.2%
1Y	-10.9%	-5.1%	3.2%

Getiri vs. Endüstri: BMX underperformed the Polish Medical Equipment industry which returned -5.1% over the past year.

Getiri vs Piyasa: BMX underperformed the Polish Market which returned 3.2% over the past year.

Fiyat Oynaklığı

Is BMX's price volatile compared to industry and market?
BMX volatility
BMX Average Weekly Movement	8.1%
Medical Equipment Industry Average Movement	6.7%
Market Average Movement	5.0%
10% most volatile stocks in PL Market	8.5%
10% least volatile stocks in PL Market	3.1%

İstikrarlı Hisse Senedi Fiyatı: BMX's share price has been volatile over the past 3 months compared to the Polish market.

Zaman İçindeki Volatilite: BMX's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Polish stocks.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
1997	115	Lukasz Urban	www.biomaxima.com

BioMaxima S.A. Polonya'da in vitro diagnostik için mikrobiyolojik besiyerleri, reaktifler ve ekipmanlar üretmekte ve dağıtmaktadır. Başlıca ürünleri arasında kan ve diğer vücut sıvılarının biyokimyasal parametrelerini test etmek için analizörler ve teşhis reaktifleri; mikroorganizmaların ilaç direncini belirleme sistemleri; bulaşıcı hastalıkları, kanser belirteçlerini, kalp krizi belirteçlerini ve bağımlılık yapan maddeleri ve okuyucuları tespit etmek için hızlı teşhis testleri; idrar analiz sistemleri; hematoloji analizörleri ve reaktifleri; iyon seçici analizörler ve reaktifler; kardiyak belirteçlerin reaktifleri ve immünolojik analizörleri; profesyonel kullanım için glukometreler ve gazometrik testler ve kritik kan parametreleri testleri için analizörler bulunmaktadır.

BioMaxima S.A. Temel Bilgiler Özeti

BioMaxima'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
BMX temel i̇stati̇sti̇kler
Piyasa değeri	zł62.27m
Kazançlar(TTM)	-zł454.00k
Gelir(TTM)	zł48.97m

1.3x

P/S Oranı

-137.2x

F/K Oranı

BMX aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
BMX gelir tablosu (TTM)
Gelir	zł48.97m
Gelir Maliyeti	zł26.76m
Brüt Kâr	zł22.21m
Diğer Giderler	zł22.67m
Kazançlar	-zł454.00k

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

Nov 29, 2024

Hisse başına kazanç (EPS)	-0.11
Brüt Marj	45.35%
Net Kâr Marjı	-0.93%
Borç/Özkaynak Oranı	24.7%

BMX uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

2.6%

Mevcut Temettü Verimi

-363%

Ödeme Oranı

BMX Stoklara Genel Bakış

Ödüller

Risk Analizi

BioMaxima S.A. Rakipler

WSE:CRM

zł41.8m

WSE:MRC

zł515.9m

WSE:MDA

zł47.7m

WSE:MDG

zł227.9m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Second quarter 2024 earnings released

BioMaxima (WSE:BMX) Is Carrying A Fair Bit Of Debt

New minor risk - Share price stability

BioMaxima S.A.'s (WSE:BMX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

New minor risk - Share price stability

BioMaxima S.A., Annual General Meeting, Jun 24, 2024

Recent updates

Second quarter 2024 earnings released

BioMaxima (WSE:BMX) Is Carrying A Fair Bit Of Debt

New minor risk - Share price stability

BioMaxima S.A.'s (WSE:BMX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

New minor risk - Share price stability

BioMaxima S.A., Annual General Meeting, Jun 24, 2024

BioMaxima S.A.'s (WSE:BMX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Investor sentiment improves as stock rises 16%

BioMaxima S.A. to Report Fiscal Year 2023 Final Results on Apr 30, 2024

Third quarter 2023 earnings released: zł0.09 loss per share (vs zł0.22 profit in 3Q 2022)

Second quarter 2023 earnings released

Returns On Capital Are Showing Encouraging Signs At BioMaxima (WSE:BMX)

New major risk - Earnings quality

Upcoming dividend of zł0.50 per share at 2.2% yield

BioMaxima S.A., Annual General Meeting, Jun 14, 2023

BioMaxima S.A. to Report Q1, 2023 Results on May 30, 2023

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: zł0.22 (vs zł0.31 in 3Q 2021)

Second quarter 2022 earnings released: EPS: zł0.80 (vs zł0.15 in 2Q 2021)

Investor sentiment deteriorated over the past week

Upcoming dividend of zł0.45 per share

Investor sentiment improved over the past week

BioMaxima S.A., Annual General Meeting, Jun 13, 2022

BioMaxima (WSE:BMX) Seems To Use Debt Quite Sensibly

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

We Think BioMaxima (WSE:BMX) Might Have The DNA Of A Multi-Bagger

BioMaxima S.A. to Report Q3, 2022 Results on Nov 28, 2022

Investor sentiment improved over the past week

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

BioMaxima (WSE:BMX) Knows How To Allocate Capital Effectively

We Think BioMaxima (WSE:BMX) Can Stay On Top Of Its Debt

Inaugural dividend of zł0.25 per share

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day high: zł36.80

Does BioMaxima (WSE:BMX) Have A Healthy Balance Sheet?

BioMaxima S.A. to Report Q3, 2021 Results on Nov 15, 2021

Are BioMaxima's (WSE:BMX) Statutory Earnings A Good Guide To Its Underlying Profitability?

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day low: zł27.60

Market pulls back on stock over the past week

Market pulls back on stock over the past week

Market pulls back on stock over the past week

Market pulls back on stock over the past week

New 90-day high: zł55.00

Market bids up stock over the past week

Market pulls back on stock over the past week

Market bids up stock over the past week

Market pulls back on stock over the past week

New 90-day high - zł36.00

Hissedar Getirileri

Fiyat Oynaklığı

Şirket Hakkında

BioMaxima S.A. Temel Bilgiler Özeti